Perrigo (PRGO) Projected to Post Quarterly Earnings on Wednesday

Perrigo (NYSE:PRGO) will likely be releasing its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect Perrigo to post earnings of $0.5070 per share and revenue of $987.20 million for the quarter. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Parties can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 8:30 AM ET.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.39 by $0.11. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the firm posted ($0.06) EPS. The company’s revenue for the quarter was down 3.1% compared to the same quarter last year. On average, analysts expect Perrigo to post $2.17 EPS for the current fiscal year and $2.35 EPS for the next fiscal year.

Perrigo Stock Up 1.4%

Shares of PRGO opened at $16.04 on Wednesday. The company has a 50 day moving average price of $14.69 and a 200-day moving average price of $12.46. Perrigo has a fifty-two week low of $9.23 and a fifty-two week high of $21.84.

Perrigo Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were issued a $0.29 dividend. The ex-dividend date was Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a yield of 7.2%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on PRGO. Weiss Ratings raised Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th. Wall Street Zen lowered Perrigo from a “strong-buy” rating to a “buy” rating in a research report on Sunday, September 27th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $17.50.

Perrigo Company Profile

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.